Abstract
The use of transgenic technologies in the functional evaluation of the contributions of costimulatory pathways to T-cell activation in vivo has recently undergone a rapid expansion. During the past two years, mice deficient in costimulatory molecules and their receptors have been generated. These mice have revealed novel and critical in vivo functions of costimulatory pathways and have provided valuable models in which to test therapeutic strategies involving costimulatory pathway blockade. Transgenic mice constitutively expressing costimulatory molecules have provided insights into their role in peripheral tolerance.
MeSH Terms
Abatacept
Animals
Antigens, CD
Antigens, Differentiation/immunology
B7-1 Antigen/immunology
CD11 Antigens/immunology
CD18 Antigens/immunology
CD2 Antigens/immunology
CD28 Antigens/immunology
CD40 Antigens/immunology
CD58 Antigens/immunology
CTLA-4 Antigen
Cell Adhesion Molecules/immunology
Cell Communication
Immunoconjugates
Integrin alpha4beta1
Integrin beta1/immunology
Integrins/immunology
Intercellular Adhesion Molecule-1/immunology
Lymphocyte Activation
Lymphocyte Function-Associated Antigen-1/immunology
Mice
Mice, Knockout/immunology
Mice, Transgenic/immunology
Receptors, Immunologic/antagonists & inhibitors
Receptors, Lymphocyte Homing/immunology
Receptors, Very Late Antigen/immunology
Signal Transduction
Vascular Cell Adhesion Molecule-1/immunology
Chemicals
Antigens, CD
Antigens, Differentiation
B7-1 Antigen
CD11 Antigens
CD18 Antigens
CD2 Antigens
CD28 Antigens
CD40 Antigens
CD58 Antigens
CTLA-4 Antigen
Cell Adhesion Molecules
Ctla4 protein, mouse
Immunoconjugates
Integrin alpha4beta1
Integrin beta1
Integrins
Lymphocyte Function-Associated Antigen-1
Receptors, Immunologic
Receptors, Lymphocyte Homing
Receptors, Very Late Antigen
Vascular Cell Adhesion Molecule-1
Intercellular Adhesion Molecule-1
Abatacept
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Sharpe A H
Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.